Received Mar 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
got COVID a month later; got COVID a month later; This is a spontaneous report received from a Physician from medical information team. A female patient received BNT162b2 (BNT162B2), in Dec2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2022, latency 1 month after the suspect product(s) administration, outcome "unknown" and all described as "got COVID a month later". Clinical course: the patient took the COVID vaccine BioNTech from Pfizer in Dec2021 and then got COVID infection in Jan2022. So, the patient got COVID the next month. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported drug ineffective / COVID-19 cannot be ruled out,Linked Report(s) : US-PFIZER INC-202500061109 Same patient, Different vaccine dose number and event;